Nov 21, 2011 by Brian Orelli, PhDThis Biotech Has Almost Everything Going for ItStressing the "almost."
Nov 18, 2011 by Brian Orelli, PhDThis Biotech Stock Rose for All the Wrong ReasonsA biotech is for sale, and the sun rises in the east.
Nov 18, 2011 by Brian Orelli, PhDMedtronic: Cutting Fat and Growing MarginsMedtronic sells off Physio-Control.
Nov 17, 2011 by Brian Orelli, PhDIn Biotech, Approval's Important, but It's the Launch That CountsWith an approval in hand, Incyte's investors are still nervous.
Nov 16, 2011 by Brian Orelli, PhDThe Only Way to Survive in This Drug MarketGilead and J&J sign another pact.
Nov 15, 2011 by Brian Orelli, PhDWhen Giving Up Is a Good Move in BiotechGeron calls it quits with stem cells.
Nov 15, 2011 by Brian Orelli, PhDGood Data, Big Drug Market, but Still RiskyEli Lilly's evacetrapib is behind Roche and Merck.
Nov 14, 2011 by Brian Orelli, PhDBiotech Uncertainty = Big Upside PotentialAastrom's phase 2 and phase 3 trials don't match up.
Nov 11, 2011 by Brian Orelli, PhDA Dividend Raise 7 Years in the MakingMerck investors get a long-awaited pay increase.
Nov 8, 2011 by Brian Orelli, PhDA Sell-the-News Buying OpportunityAriad gets knocked down despite presenting good data.
Nov 4, 2011 by Brian Orelli, PhDYou Should Have Seen These Biotech Failures ComingMicrocap biotechs are a value for a reason.
Nov 3, 2011 by Brian Orelli, PhDFDA Approves! Investors Shrug.Investors just aren't that into MELA Sciences' newly approved melanoma detection device.
Nov 3, 2011 by Brian Orelli, PhDModest Growth, Less-Than-Modest Stock DropDendreon's investors aren't happy.
Nov 2, 2011 by Brian Orelli, PhDLipitor Loss Looming, Pfizer ShinesGood thing it's already priced in.
Nov 1, 2011 by Brian Orelli, PhDNot Such an Excellent Outcome With the FDAExelixis gets knocked down for not getting an SPA.
Oct 31, 2011 by Brian Orelli, PhDSpectrum Looking More InvestableValuing the company is still difficult, though.
Oct 31, 2011 by Brian Orelli, PhDThe Big Bet on Cell TherapeuticsWill the FDA change its mind about pixantrone?
Oct 31, 2011 by Brian Orelli, PhDWhen You've Got It, You've Got ItBiogen keeps its good-news streak going.
